Bio-Works Technologies AB (publ)
BIOWKS.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$250.84M
Close$
Share Statistics
| Market cap | $250.84 Million |
|---|---|
| Enterprise Value | $221.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 0.68 |
| Outstanding Shares | 100,010,822 |
Return
| Return on Equity | 4.16% |
|---|---|
| Return on Assets | 3.57% |
| Return on Invested Capital | -0.27% |
Valuation & Multiples
| P/E Ratio | 199.34 |
|---|---|
| PEG | -302.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.47 |
| Enterprise Value to EBIT | -1561.69 |
| Enterprise Value to Net Income | 100 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bio-Works Technologies AB (publ)
32 employees
CEO: Lone Carlbom Bio-Works Technologies AB (publ) is a biotechnology company that specializes in the research, development, production, and distribution of agarose-based separation products. These sophisticated solutions are designed to facilitate the pu...